Trial Profile
Phase II trial of NEU 2000 in patients with ischaemic stroke.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 May 2008
Price :
$35
*
At a glance
- Drugs Nelonemdaz (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors AmKor Pharma
- 05 May 2008 New trial record.
- 23 Apr 2008 AmKor stated in a media release that this trial will be initiated in 2008.